Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
| Distributed by / for | Akorn, Inc. |
| Full product label | Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07 |
| Recalling firm | Akorn, Inc. |
| Distribution | Nationwide USA |
| Quantity | 8,183 unit dose cups |
| Recall initiated | 2021-03-08 |
| Report date | 2021-03-24 |
| Recall completed | 2022-08-09 |
| Recall number | D-0301-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Lake Forest IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗